The University of Chicago Header Logo

Connection

Chang Sun to Solubility

This is a "connection" page, showing publications Chang Sun has written about Solubility.
Connection Strength

8.427
  1. Impact of route of particle engineering on dissolution performance of posaconazole. Int J Pharm. 2025 Jan 25; 669:125025.
    View in: PubMed
    Score: 0.910
  2. Relative Bioavailability Assessment of Solid Forms by An Artificial Stomach and Duodenum Apparatus. J Pharm Sci. 2024 Aug; 113(8):2506-2512.
    View in: PubMed
    Score: 0.876
  3. Mechanism for the Reduced Dissolution of Ritonavir Tablets by Sodium Lauryl Sulfate. J Pharm Sci. 2019 Jan; 108(1):516-524.
    View in: PubMed
    Score: 0.596
  4. Decreased Crystal Plasticity by Solvation - the Case of Levofloxacin Acesulfame. Mol Pharm. 2025 Mar 03; 22(3):1598-1604.
    View in: PubMed
    Score: 0.230
  5. Direct compression tablet formulation of trimetazidine through systematic screening of oxalate salts. Int J Pharm. 2025 Feb 25; 671:125255.
    View in: PubMed
    Score: 0.230
  6. Simultaneously improving tabletability and solubility of diclofenac by cocrystallization with picolinamide. Int J Pharm. 2025 Feb 10; 670:125172.
    View in: PubMed
    Score: 0.229
  7. Advancing the Harmonization of Biopredictive Methodologies through the Product Quality Research Institute (PQRI) Consortium: Biopredictive Dissolution of Dipyridamole Tablets. Mol Pharm. 2024 Oct 07; 21(10):5315-5325.
    View in: PubMed
    Score: 0.224
  8. Efficient determination of critical water activity and classification of hydrate-anhydrate stability relationship. J Pharm Sci. 2025 Jan; 114(1):127-135.
    View in: PubMed
    Score: 0.221
  9. Delaying the first nucleation event of amorphous solid dispersions above the polymer overlap concentration (c*): PVP and PVPVA in posaconazole. J Pharm Sci. 2025 Jan; 114(1):98-104.
    View in: PubMed
    Score: 0.218
  10. Modulating Pharmaceutical Properties of Berberine Chloride through Cocrystallization with Benzendiol Isomers. Pharm Res. 2023 Dec; 40(12):2791-2800.
    View in: PubMed
    Score: 0.205
  11. Profound effects of gastric secretion rate variations on the precipitation of erlotinib in duodenum - An in vitro investigation. Int J Pharm. 2022 May 10; 619:121722.
    View in: PubMed
    Score: 0.189
  12. Complexation with aromatic carboxylic acids expands the solid-state landscape of berberine. Int J Pharm. 2022 Apr 05; 617:121587.
    View in: PubMed
    Score: 0.187
  13. Simultaneous improvement of physical stability, dissolution, bioavailability, and antithrombus efficacy of Aspirin and Ligustrazine through cocrystallization. Int J Pharm. 2022 Mar 25; 616:121541.
    View in: PubMed
    Score: 0.187
  14. Formulation strategies for mitigating dissolution reduction of p-aminobenzoic acid by sodium lauryl sulfate through diffusion layer modulation. Int J Pharm. 2022 Jan 05; 611:121310.
    View in: PubMed
    Score: 0.184
  15. Pharmaceutical Lauryl Sulfate Salts: Prevalence, Formation Rules, and Formulation Implications. Mol Pharm. 2022 02 07; 19(2):432-439.
    View in: PubMed
    Score: 0.183
  16. Efficient development of sorafenib tablets with improved oral bioavailability enabled by coprecipitated amorphous solid dispersion. Int J Pharm. 2021 Dec 15; 610:121216.
    View in: PubMed
    Score: 0.183
  17. Novel Salt-Cocrystals of Berberine Hydrochloride with Aliphatic Dicarboxylic Acids: Odd-Even Alternation in Physicochemical Properties. Mol Pharm. 2021 04 05; 18(4):1758-1767.
    View in: PubMed
    Score: 0.175
  18. Development of piroxicam mini-tablets enabled by spherical cocrystallization. Int J Pharm. 2020 Nov 30; 590:119953.
    View in: PubMed
    Score: 0.171
  19. The efficient development of a sildenafil orally disintegrating tablet using a material sparing and expedited approach. Int J Pharm. 2020 Nov 15; 589:119816.
    View in: PubMed
    Score: 0.169
  20. Material-Sparing and Expedited Development of a Tablet Formulation of Carbamazepine Glutaric Acid Cocrystal- a QbD Approach. Pharm Res. 2020 Jul 23; 37(8):153.
    View in: PubMed
    Score: 0.168
  21. A microcrystalline cellulose based drug-composite formulation strategy for developing low dose drug tablets. Int J Pharm. 2020 Jul 30; 585:119517.
    View in: PubMed
    Score: 0.167
  22. Simultaneous taste-masking and oral bioavailability enhancement of Ligustrazine by forming sweet salts. Int J Pharm. 2020 Mar 15; 577:119089.
    View in: PubMed
    Score: 0.163
  23. A systematic evaluation of poloxamers as tablet lubricants. Int J Pharm. 2020 Feb 25; 576:118994.
    View in: PubMed
    Score: 0.162
  24. Crystallographic and Energetic Insights into Reduced Dissolution and Physical Stability of a Drug-Surfactant Salt: The Case of Norfloxacin Lauryl Sulfate. Mol Pharm. 2020 02 03; 17(2):579-587.
    View in: PubMed
    Score: 0.162
  25. Microstructures and pharmaceutical properties of ferulic acid agglomerates prepared by different spherical crystallization methods. Int J Pharm. 2020 Jan 25; 574:118914.
    View in: PubMed
    Score: 0.161
  26. Expedited Tablet Formulation Development of a Highly Soluble Carbamazepine Cocrystal Enabled by Precipitation Inhibition in Diffusion Layer. Pharm Res. 2019 Apr 23; 36(6):90.
    View in: PubMed
    Score: 0.154
  27. Improving solid-state properties of berberine chloride through forming a salt cocrystal with citric acid. Int J Pharm. 2019 Jan 10; 554:14-20.
    View in: PubMed
    Score: 0.149
  28. Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer. Pharm Res. 2017 12 29; 35(1):4.
    View in: PubMed
    Score: 0.141
  29. Expedited Development of Diphenhydramine Orally Disintegrating Tablet through Integrated Crystal and Particle Engineering. Mol Pharm. 2017 10 02; 14(10):3399-3408.
    View in: PubMed
    Score: 0.138
  30. Expedited development of a high dose orally disintegrating metformin tablet enabled by sweet salt formation with acesulfame. Int J Pharm. 2017 Oct 30; 532(1):435-443.
    View in: PubMed
    Score: 0.137
  31. Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression. J Pharm Sci. 2017 07; 106(7):1772-1777.
    View in: PubMed
    Score: 0.133
  32. Mechanical Properties and Tableting Behavior of Amorphous Solid Dispersions. J Pharm Sci. 2017 01; 106(1):217-223.
    View in: PubMed
    Score: 0.130
  33. The development of carbamazepine-succinic acid cocrystal tablet formulations with improved in vitro and in vivo performance. Drug Dev Ind Pharm. 2016; 42(6):969-76.
    View in: PubMed
    Score: 0.121
  34. Validation and applications of an expedited tablet friability method. Int J Pharm. 2015 Apr 30; 484(1-2):146-55.
    View in: PubMed
    Score: 0.116
  35. Cocrystallization for successful drug delivery. Expert Opin Drug Deliv. 2013 Feb; 10(2):201-13.
    View in: PubMed
    Score: 0.099
  36. Simultaneously improving the mechanical properties, dissolution performance, and hygroscopicity of ibuprofen and flurbiprofen by cocrystallization with nicotinamide. Pharm Res. 2012 Jul; 29(7):1854-65.
    View in: PubMed
    Score: 0.094
  37. Solid-state properties and crystallization behavior of PHA-739521 polymorphs. Int J Pharm. 2006 Aug 17; 319(1-2):114-20.
    View in: PubMed
    Score: 0.062
  38. Miscibility of amorphous solid dispersions: A rheological and solid-state NMR spectroscopy study. J Pharm Sci. 2025 Jan; 114(1):119-126.
    View in: PubMed
    Score: 0.055
  39. Development of direct compression Acetazolamide tablet with improved bioavailability in healthy human volunteers enabled by cocrystallization with p-Aminobenzoic acid. Int J Pharm. 2024 Mar 05; 652:123793.
    View in: PubMed
    Score: 0.053
  40. Harmonizing Biopredictive Methodologies Through the Product Quality Research Institute (PQRI) Part I: Biopredictive Dissolution of Ibuprofen and Dipyridamole Tablets. AAPS J. 2023 04 21; 25(3):45.
    View in: PubMed
    Score: 0.051
  41. A Rheological Approach for Predicting Physical Stability of Amorphous Solid Dispersions. J Pharm Sci. 2023 01; 112(1):204-212.
    View in: PubMed
    Score: 0.049
  42. The impact of solid-state form, water content and surface area of magnesium stearate on lubrication efficiency, tabletability, and dissolution. Pharm Dev Technol. 2021 Feb; 26(2):150-156.
    View in: PubMed
    Score: 0.043
  43. Polymer Nanocoating of Amorphous Drugs for Improving Stability, Dissolution, Powder Flow, and Tabletability: The Case of Chitosan-Coated Indomethacin. Mol Pharm. 2019 03 04; 16(3):1305-1311.
    View in: PubMed
    Score: 0.038
  44. Dapagliflozin-citric acid cocrystal showing better solid state properties than dapagliflozin. Eur J Pharm Sci. 2017 Jun 15; 104:255-261.
    View in: PubMed
    Score: 0.033
  45. Resveratrol cocrystals with enhanced solubility and tabletability. Int J Pharm. 2016 Jul 25; 509(1-2):391-399.
    View in: PubMed
    Score: 0.032
  46. Designing micellar nanocarriers with improved drug loading and stability based on solubility parameter. Mol Pharm. 2015 Mar 02; 12(3):816-25.
    View in: PubMed
    Score: 0.029
  47. Characterization of thermal behavior of deep eutectic solvents and their potential as drug solubilization vehicles. Int J Pharm. 2009 Aug 13; 378(1-2):136-9.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.